SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of LivaNova PLC Investors

NEW YORK, July 18, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors in LivaNova PLC (“LivaNova” or the “Company”) (NASDAQ: LIVN). Such investors are advised to contact Danielle Peyton at (email protected) or 646-581-9980, extension 7980.

The investigation concerns whether LivaNova and certain of its officers and/or directors engaged in securities transactions. Fraud or other unlawful business practices.

(Click here for information on joining the class action lawsuit.)

At June 6, 2024LivaNova issued a press release announcing “preliminary results from the unipolar patient cohort of the RECOVER clinical trial evaluating the use of VNS Therapy™ in treatment-resistant depression,” and noted that “the trial did not meet its primary endpoint (PE) for the unipolar cohort(.).”

Following this news, LivaNova’s share price fell $7.23 per share or 12.04% and closed at 52,80 € per share on June 6, 2024.

Pomerantz LLP, with offices in new York, Chicago, Los Angeles, London, ParisAnd Tel-Avivis considered one of the leading law firms in the areas of corporate, securities and antitrust litigation. Founded by the late Abraham L. PomerantzKnown as the dean of class action lawyers, Pomerantz was a pioneer in the field of securities class action litigation. Today, more than 85 years later, Pomerantz continues the tradition he established and fights for the rights of securities litigation victims. FraudBreach of fiduciary duty and corporate misconduct. The firm has won billions of dollars in damages on behalf of class action plaintiffs. See www.pomlaw.com.

Attorney advertising. Past results do not guarantee similar results.

CONTACT:
Danielle Peyton
Pomerantz LLP
(email protected)
646-581-9980 extension 7980

Never miss a story from Pomerantz LLP again.